Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Burgos
Clinical trial register · Spain

Clinical Trials in Burgos, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca6 Janssen Research & Development, LLC4 Universidad de Burgos3 BeOne Medicines3 Daiichi Sankyo3
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Burgos

74 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
AstraZeneca
Phase 3
7,000
Badajoz, Barcelona, Burgos, Córdoba, Granada, Madrid, Majadahonda, Málaga
2026-08-21
Not yet open
Hospital Universitari Vall d'Hebron Research Institute
Phase 3
15,160
Granada, Barcelona, Girona, Tarragona, Barakaldo, A Coruña, Alicante, Burgos
2026-07-01
Recruiting
ViiV Healthcare
Phase 3
564
Pozuelo de Alarcón, Alicante, Badalona, Barcelona, Burgos, Cartagena Murcia, Córdoba, Elche Alicante
2026-06-25
Recruiting
AstraZeneca
Phase 3
150
Badajoz, Badalona, Barcelona, Burgos, Donostia / San Sebastian, Huelva, Jaén, Las Palmas de Gran Canaria
2026-06-15
Recruiting
PETHEMA Foundation
Phase 2
50
Albacete, Alicante, Burgos, Cáceres, Córdoba, Las Palmas, Las Palmas de Gran Canaria, Lugo
2026-06-12
Not yet open
Universidad de Burgos
Not applicable
20
Burgos
2026-05-01
Active, closed
Universidad de Burgos
Not applicable
50
Burgos
2026-03-10
Recruiting
Evaluation of a Multicomponent Early Intervention for Childhood Obesity Prevention in Vulnerable Families
NCT07529704Obesity & Overweight, Vulnerable Families, Children, Families With Infants
Helena Vall Roqué
Not applicable
526
Burgos, Barcelona, Palma de Mallorca, Seville
2026-03-02
Recruiting
Boehringer Ingelheim
Phase 3
400
Barcelona, Burgos, Elche, Jerez de la Frontera, Madrid, Majadahonda, Málaga, Pamplona
2026-01-16
Recruiting
Syndax Pharmaceuticals
Phase 3
468
Badalona, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Santander, Oviedo, Alicante, Barcelona, Burgos
2025-11-25
Recruiting
Sanofi
Phase 3
60
Barcelona, Burgos, Madrid, Murcia, San Cristóbal de La Laguna, Seville
2025-10-24
Recruiting
Daiichi Sankyo
Phase 3
686
A Coruña, Barcelona, Burgos, Castellion, Las Palmas de Gran Canaria, Lugo, Madrid, Málaga
2025-10-24
Recruiting
A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy
NCT07785180Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Stemline Therapeutics, Inc.
Observational
140
Albacete, Alicante, Badalona, Burgos, Cáceres, Córdoba, Madrid, Oviedo
2025-10-17
Not yet open
Instituto de Investigación Marqués de Valdecilla
Not applicable
220
Burgos, Salamanca, Santander
2025-10-01
Recruiting
Kura Oncology, Inc.
Phase 3
1,300
Seville, Zaragoza, Burgos, Salamanca, Albacete, Madrid, Oviedo, Valencia
2025-09-26
Recruiting
Universidad de Burgos
Not applicable
50
Burgos
2025-09-15
Recruiting
AstraZeneca
Phase 2
55
A Coruña, Alcorcón, Badalona, Barcelona, Burgos, Donostia / San Sebastian, Gijón, Madrid
2025-09-05
Recruiting
BeOne Medicines
Phase 3
500
Badalona, Burgos, Las Palmas de Gran Canaria, Madrid, Majadahonda, Palma de Mallorca, Seville
2025-09-04
Recruiting
Takeda
Phase 3
150
Alcorcón, Madrid, Burgos, Salamanca, Seville
2025-08-14
Recruiting
Kedrion S.p.A.
Phase 3
40
Burgos, A Coruña, Madrid
2025-08-13
Recruiting
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Phase 2
80
Seville, Zaragoza, Palma de Mallorca, Burgos, Salamanca, Badalona, Barcelona, Cáceres
2025-08-04
Recruiting
Eli Lilly and Company
Phase 1/2
68
Barcelona, Burgos, Murcia, Pamplona
2025-07-30
Recruiting
A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)
NCT07043946Immune Thrombocytopenia (ITP), ITP, Biologics, Monoclonal
DrugBudoprutug
Climb Bio, Inc.
Phase 1/2
24
Burgos, Madrid, San Pedro, Valencia
2025-06-30
Recruiting
Grupo Espanol de Tumores Neuroendocrinos
Phase 3
166
Barcelona, L'Hospitalet de Llobregat, Burgos, Granada, Madrid, Oviedo, Seville, Valencia
2025-06-12
Recruiting
Grupo Español Multidisciplinar de Melanoma
Phase 2
33
A Coruña, Barcelona, Burgos, Santander, Cáceres, Donostia / San Sebastian, Madrid, Majadahonda
2025-05-29
Recruiting
AstraZeneca
Phase 3
400
Alcorcón, Alzira (Valencia), Badalona, Barakaldo, Barcelona, Burgos, Cáceres, Granada
2025-03-28
Recruiting
Daiichi Sankyo
Phase 3
510
Burgos, Elche, L'Hospitalet de Llobregat, Madrid, Málaga, Ourense, Oviedo, Pamplona
2025-03-27
Recruiting
Instituto de Investigación Marqués de Valdecilla
Observational
330
Santander, Alicante, Barcelona, Bilbao, Burgos, Madrid, Oviedo, Toledo
2025-03-01
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,000
Albacete, Alicante, Barakaldo, Burgos, Cadiz, Cantabria, Córdoba, Donostia / San Sebastian
2025-02-12
Active, closed
FUNDACIÓN HOSPITAL UNIVERSITARIO INFANTA LEONOR Y DEL HOSPITAL UNIVERSITARIO DEL SURESTE
Observational
3,346
Burgos
2024-12-31
Recruiting
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
NCT06382948Advanced Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer, ESR1 Gene Mutation
DrugsElacestrant·Everolimus
MedSIR
Phase 3
300
Barcelona, A Coruña, Alicante, Badalona, Bilbao, Burgos, Castellon, Cáceres
2024-12-05
Active, closed
Daiichi Sankyo
Phase 3
700
Albacete, Alicante, Badalona, Barcelona, Burgos, Cáceres, Córdoba, Las Palmas
2024-11-19
Recruiting
Fundación para la Investigación del Hospital Clínico de Valencia
Phase 3
94
Alcorcón, Leganés, Albacete, Burgos, Córdoba, Valencia
2024-10-03
Active, closed
Noema Pharma AG
Phase 2
164
Barcelona, Burgos, Madrid, Oviedo, Sant Cugat del Vallès, Seville
2024-09-10
Recruiting
Amgen
Phase 3
450
Córdoba, Granada, Málaga, Seville, Zaragoza, Santander, Burgos, Badalona
2024-07-17
Recruiting
Reduction of the Incidence of NAV in Neonatal Units (INBERNAV-Neo)
NCT07240038Pneumonia Ventilator Associated, Pneumonia Neonatal, Healthcare-associated Infections
Biobizkaia Health Research Institute
Observational
1,500
A Coruña, Santiago de Compostela, Albacete, Badalona, Barcelona, Barakaldo, Bilbao, Burgos
2024-04-26
Recruiting
Pesticides and Parkinson´s Disease
NCT06420310Pesticide-Induced Parkinsonism
Hospital Universitario de Burgos
Observational
260
Burgos
2024-04-01
Recruiting
Hospital Universitario La Fe
Not applicable
1,272
Huelva, Valencia, A Coruña, Burgos, Castelló, Córdoba, Elche, Granada
2024-03-11
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Asturias, Barcelona, Burgos, Cáceres, Donostia / San Sebastian, Granada, Lugo, Madrid
2024-01-22
Recruiting
Hospital Universitario Central de Asturias
Observational
100
A Coruña, Badalona, Barcelona, Burgos, Donostia / San Sebastian, Madrid, Málaga, Oviedo
2024-01-12
Active, closed
Bioprojet
Phase 2
62
Barcelona, Burgos
2023-12-20
Recruiting
Observational Study Protocol: LIVER-R
NCT06252753Hepatobiliary Cancers
AstraZeneca
Observational
4,000
Santiago de Compostela, Zaragoza, Poniente Sur, Santander, Burgos, Ourense, Majadahonda, El Palmar
2023-12-20
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,314
Sabadell, Barcelona, Girona, A Coruña, Las Palmas de Gran Canaria, Pozuelo de Alarcón, Burgos, Málaga
2023-12-18
Active, closed
BeOne Medicines
Phase 3
652
Burgos, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Madrid, Santa Cruz de Tenerife
2023-11-11
Active, closed
AstraZeneca
Phase 3
5,511
A Coruña, Albacete, Alicante, Badalona, Barakaldo, Barcelona, Burgos, Castellon
2023-10-05
Active, closed
Zenas BioPharma (USA), LLC
Phase 3
134
Burgos, Madrid
2023-09-25
Active, closed
Novartis Pharmaceuticals
Phase 2
144
Barakaldo, Barcelona, Burgos, Madrid
2023-08-25
Recruiting
Fundación Española de Hematología y Hemoterapía
Observational
210
Vitoria-Gasteiz, Almería, Palma de Mallorca, Sabadell, Burgos, Valdepeñas, Girona, Granada
2023-05-30
Active, closed
Facilitators and Barriers in Neuroscience-based Pain Education Programmes in Primary Care Physiotherapy
NCT05860816Chronic Primary Pain, Musculoskeletal Pain, Fibromyalgia
Castilla-León Health Service
Observational
123
Burgos
2023-05-12
Active, closed
Hoffmann-La Roche
Phase 2
301
Barakaldo, Badajoz, Barcelona, Burgos, Madrid, Seville, Valencia
2023-02-03
Active, closed
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase 3
129
Barcelona, Burgos, A Coruña, Granada, Madrid, Murcia, Málaga, Salamanca
2022-12-02
Recruiting
PETHEMA Foundation
Phase 3
480
Alcalá de Henares, Pozuelo de Alarcón, Pamplona, Albacete, Badalona, Barcelona, Bilbao, Burgos
2022-11-10
Active, closed
Utility of CYP2D6 Genotyping to Improve the Efficacy and Safety of Tramadol
NCT05657704Post-surgical Pain, Pain, Acute, Postoperative Pain
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Phase 4
300
Majadahonda, Alicante, Burgos, Madrid
2022-10-05
Active, closed
Eli Lilly and Company
Phase 3
8,000
A Coruña, Alicante, Almería, Badajoz, Barcelona, Bilbao, Burgos, Cáceres
2022-10-04
Recruiting
Bristol-Myers Squibb
Observational
1,700
Palma de Mallorca, Majadahonda, El Palmar, Oviedo, Burgos, Madrid, Málaga
2022-08-16
Recruiting
Neck Evolution With Ovation in Spain
NCT05823519Abdominal Aortic Aneurysm
DGM Vascular
Observational
120
Palma de Mallorca, Girona, Barakaldo, Burgos, Salamanca, Toledo, Gijón, Barcelona
2022-06-01
Active, closed
BeOne Medicines
Phase 3
799
Badalona, Burgos, Cadiz, Granada, L'Hospitalet de Llobregat, León, Madrid, Majadahonda
2022-03-10
Recruiting
ImmunoVaccine Technologies, Inc. (IMV Inc.)
Phase 2
102
Barcelona, Burgos, Seville
2021-06-18
Active, closed
Incyte Corporation
Phase 3
654
A Coruña, Alicante, Badalona, Barcelona, Burgos, Gijón, L'Hospitalet de Llobregat, Madrid
2021-04-15
Active, closed
GlaxoSmithKline
Phase 2/3
758
A Coruña, Badalona, Barcelona, Burgos, Córdoba, Las Palmas de Gran Canar, Madrid, Málaga
2020-12-08
Recruiting
International Validation of Two Non-motor Scales in PD (NFS and SPARK)
NCT04366804Parkinson's Disease, Non-motor Symptoms
Insel Gruppe AG, University Hospital Bern
Observational
300
Burgos, Madrid
2020-12-03
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Pamplona, A Coruña, Badalona, Barcelona, Bilbao, Burgos, Jerez de la Frontera, Las Palmas de Gran Canaria
2020-12-02
Active, closed
Janssen Research & Development, LLC
Phase 3
308
A Coruña, Badalona, Barcelona, Burgos, Madrid, Majadahonda, Málaga, Pamplona
2020-10-13
Active, closed
Janssen Research & Development, LLC
Phase 3
1,074
A Coruña, Badalona, Barcelona, Burgos, Girona, Madrid, Majadahonda, Málaga
2020-09-30
Active, closed
CStone Pharmaceuticals
Phase 3
534
A Coruña, Ourense, Majadahonda, Oviedo, Ávila, Barcelona, Burgos, Girona
2019-12-13
Active, closed
NeuroDerm Ltd.
Phase 3
381
Oviedo, Alicante, Barcelona, Burgos, Madrid, Seville, Valencia
2019-09-30
Active, closed
Janssen Research & Development, LLC
Phase 2/3
118
Alcalá de Henares, Badalona, Barcelona, Burgos, Córdoba, Las Palmas de Gran Canaria, Madrid, Majadahonda
2019-08-15
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Donostia / San Sebastian, Majadahonda, Pamplona, A Coruña, Alicante, Badalona, Barcelona, Burgos
2019-08-09
Active, closed
Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain
NCT03605771Melanoma Stage Iv, Melanoma Stage Iii, Advanced Cancer
Grupo Español Multidisciplinar de Melanoma
Observational
400
Alcoy, Granada, Málaga, Barcelona, Sabadell, Vitoria-Gasteiz, Santander, Burgos
2018-08-07
Active, closed
A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.
NCT03504397Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Folinic acid·Fluorouracil·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
565
Badalona, Ávila, Alcorcón, Barcelona, Burgos, Madrid, Murcia, Seville
2018-06-21
Active, closed
Biotronik SE & Co. KG
Observational
3,030
Alicante, Barcelona, Burgos, Donostia / San Sebastian, Madrid, Málaga, Valencia, Vigo
2018-05-14
Active, closed
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Phase 2
50
Barcelona, Terrassa, Burgos, Alcorcón, Madrid, Cartagena, Marbella, Seville
2016-05-18
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
5,796
A Coruña, Alicante, Badalona, Barcelona, Burgos, Castellon, Cáceres, Córdoba
2015-08
Recruiting
CHDI Foundation, Inc.
Observational
35,000
Badajoz, Barakaldo, Barcelona, Burgos, Madrid, Palma de Mallorca, Pamplona, Valencia
2012-07
Rows per page Showing 1–74 of 74
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/burgos

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 74 of those studies with a site in Burgos.

How many clinical trials are recruiting in Burgos?

42 of the 74 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 3 have not yet opened recruitment, 29 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Burgos), 74 studies
PhaseStudiesRecruitingShare
Phase 3351947.3%
Observational161121.6%
Phase 211614.9%
Not applicable638.1%
Phase 2/3314.1%
Phase 1/2222.7%
Phase 4101.4%

Most active sponsors

Lead sponsors with the most studies (Burgos)
Lead sponsorStudiesRecruiting
AstraZeneca65
Janssen Research & Development, LLC40
BeOne Medicines31
Daiichi Sankyo32
Universidad de Burgos31
Bristol-Myers Squibb22
Eli Lilly and Company21
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea21
Grupo Español Multidisciplinar de Melanoma21
Instituto de Investigación Marqués de Valdecilla21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.